Pharmacy News

Subscribe to Pharmacy News feed
PharmaTimes - The latest news in healthcare and life sciences - News RSS
Updated: 2 hours 40 min ago

NICE, PHE publish antimicrobial prescribing guidance on pneumonia

16/09/2019
New recommendations have been added to highlight that antibiotic treatment should be started as soon as possible - no more than four hours after diagnosis and one hour if sepsis is suspected.

BioMarin’s Brineura made available on NHS

16/09/2019
The £500,000 per patient drug was deemed too costly for use in February 2018.

FDA approves Nucala

13/09/2019
The treatment was also recently made available in two new formulations in the UK, a pre-filled pen and a pre-filled syringe.

Ipsen opens new Milton Park research centre

13/09/2019
The centre will enable scientists to “better support the development of current and future biological medicines.”

‘Collaborative vision’ could speed up access to medicines

13/09/2019
Currently less than 50% of orphan medicines are routinely funded in England, Scotland and Wales.

First patient dosed in Fabry Disease gene therapy trial

13/09/2019
The study is the first clinical-stage adeno-associated virus (AAV) gene therapy study globally for Fabry Disease.

Seven new data hubs to be rolled out across UK

13/09/2019
The hubs will be the home of “cutting-edge research” for health discoveries.

Keyhole hysterectomy surgery ‘safer and more effective’

13/09/2019
The technique removes just part of the uterus using a keyhole surgery.

Final chance to enter into the 2019 Communications Team of the Year & Marketer of the Year!

13/09/2019
Entry for the 2019 Communications Team of the Year and Marketer of the Year competitions will be closing for entry on Monday the 16th of September.

Launch of health technology accelerator programme

12/09/2019
Just 15 participants were selected for the The Greater Manchester Future of Health Challenge.

Mavenclad real-world data shows sustained efficacy

12/09/2019
75% of treated MS patients showed no disability progression at five years post-treatment.

Novartis’ Mayzent could preserve mobility in MS patients

12/09/2019
The average time to when patients require a wheelchair could be extended from 12 years to 16.3 years.

BMS’ Opdivo shows long-term survival benefit

12/09/2019
Opdivo-treated patients continued to experience long-term overall survival benefits compared to docetaxel.

SMC U-turn for Vertex’s CF drugs

12/09/2019
Back in August, the committee rejected Orkambi and Symveki following consideration through PACE.

MSEA 2018 winner shares how the finals day has helped to enhance his area of expertise

12/09/2019
The 2018 winner of the New Medical Science Liaison of the Year shares his experience with the competition and how it has helped to sharpen his skills.

Parsortix test could avoid unnecessary prostate biopsies

11/09/2019
Currently, investigation of symptoms for prostate cancer is typically made via an invasive blood test.

MSD initiates late-stage MS study

11/09/2019
The previous Phase II trial met its primary endpoint.

Gilead, Elton John AIDS Foundation launch HIV initiative

11/09/2019
The pharma giant announced the “ground-breaking” RADIAN initiative at the Fast-Track Cities 2019 conference in London.

Government injects £130m into cancer & debilitating illnesses

11/09/2019
Thousands of NHS patients could receive faster diagnosis and better treatment for life-changing diseases like cancer, dementia and Parkinson’s.

Kymriah leads latest round of SMC decisions

11/09/2019
MSD’s Keytruda, Pfizer’s Visimpro, AstraZeneca’s Forxiga and Shionogi’s Senshio were also accepted.

Pages

X